Pacer Advisors
BIVV

Pacer Advisors’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Pacer Advisors’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-29,449
Closed -$1.59M – 1193
2017
Q4 		$1.59M Buy
29,449
+11,767
+67% +$644K 0.11% 225
2017
Q3 		$1.01M Buy
17,682
+1,809
+11% +$106K 0.09% 288
2017
Q2 		$955K Buy
15,873
+1,026
+7% +$58.4K 0.09% 260
2017
Q1 		$809K Buy
+14,847
New +$731K 0.1% 260

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Pacer Advisors's BIVV Position: Q1 2018 in Review

Pacer Advisors sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 29,449 shares — an estimated $1.59M sold.

Pacer Advisors first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $1.59M in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Pacer Advisors reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Pacer Advisors sold 29,449 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $1.59M.
  • Pacer Advisors first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Pacer Advisors's Bioverativ Inc. Common Stock position peaked at $1.59M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Pacer Advisors's 13F filing for Q1 2018, filed 14 May 2018.